Jan F Mieves1, Kirsten Wittke1, Helma Freitag1, Hans-Dieter Volk1,2, Carmen Scheibenbogen1, Leif G Hanitsch3. 1. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Medical Immunology, Augustenburger Platz 1, 13353, Berlin, Germany. 2. Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Medicine Berlin, Berlin, Germany. 3. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Medical Immunology, Augustenburger Platz 1, 13353, Berlin, Germany. leif-gunnar.hanitsch@charite.de.
Abstract
PURPOSE OF REVIEW: Vaccination against influenza in patients with primary antibody deficiency is recommended. Common variable immunodeficiency (CVID) is the most frequent and clinically relevant antibody deficiency disease and is by definition characterized by an impaired vaccination response. The purpose of this review is to present the current knowledge of humoral and cellular vaccine response to influenza in CVID patients. RECENT FINDINGS: Studies conducted in CVID patients demonstrated an impaired humoral response upon influenza vaccination. Data on cellular immune response are in part conflicting, with two out of three studies showing responses similar to healthy controls. Available data suggest a benefit from influenza vaccination in CVID patients. Therefore, annual influenza vaccination in patients and their close household contacts is recommended.
PURPOSE OF REVIEW: Vaccination against influenza in patients with primary antibody deficiency is recommended. Common variable immunodeficiency (CVID) is the most frequent and clinically relevant antibody deficiency disease and is by definition characterized by an impaired vaccination response. The purpose of this review is to present the current knowledge of humoral and cellular vaccine response to influenza in CVIDpatients. RECENT FINDINGS: Studies conducted in CVIDpatients demonstrated an impaired humoral response upon influenza vaccination. Data on cellular immune response are in part conflicting, with two out of three studies showing responses similar to healthy controls. Available data suggest a benefit from influenza vaccination in CVIDpatients. Therefore, annual influenza vaccination in patients and their close household contacts is recommended.
Entities:
Keywords:
Common variable immunodeficiency; Influenza; Primary antibody deficiency; Vaccination
Authors: Steven Black; Uwe Nicolay; Timo Vesikari; Markus Knuf; Giuseppe Del Giudice; Giovanni Della Cioppa; Theodore Tsai; Ralf Clemens; Rino Rappuoli Journal: Pediatr Infect Dis J Date: 2011-12 Impact factor: 2.129
Authors: Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu Journal: Nat Med Date: 2012-01-29 Impact factor: 53.440
Authors: Timo Vesikari; Markus Knuf; Peter Wutzler; Aino Karvonen; Dorothee Kieninger-Baum; Heinz-Josef Schmitt; Frank Baehner; Astrid Borkowski; Theodore F Tsai; Ralf Clemens Journal: N Engl J Med Date: 2011-10-13 Impact factor: 91.245
Authors: Gemma E Hartley; Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robert G Stirling; Paul U Cameron; Katie Flanagan; Magdalena Plebanski; Philip Mark Hogarth; Robyn E O'Hehir; Menno C van Zelm Journal: Clin Transl Immunology Date: 2020-10-16
Authors: Daniel Arroyo-Sánchez; Oscar Cabrera-Marante; Rocío Laguna-Goya; Patricia Almendro-Vázquez; Octavio Carretero; Francisco Javier Gil-Etayo; Patricia Suàrez-Fernández; Pilar Pérez-Romero; Edgard Rodríguez de Frías; Antonio Serrano; Luis M Allende; Daniel Pleguezuelo; Estela Paz-Artal Journal: J Clin Immunol Date: 2021-11-17 Impact factor: 8.317
Authors: Kai M T Sauerwein; Christoph B Geier; Roman F Stemberger; Hüseyin Akyaman; Peter Illes; Michael B Fischer; Martha M Eibl; Jolan E Walter; Hermann M Wolf Journal: Front Immunol Date: 2022-02-14 Impact factor: 7.561
Authors: Sneha Suresh; Joseline Zafack; Anne Pham-Huy; Beata Derfalvi; Manish Sadarangani; Athena McConnell; Bruce Tapiéro; Scott A Halperin; Gaston De Serres; Jeffrey M Pernica; Karina A Top Journal: Allergy Asthma Clin Immunol Date: 2022-04-09 Impact factor: 3.406